| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Communication | 40 | 2025 | 587 | 6.810 |
Why?
|
| Physician-Patient Relations | 36 | 2025 | 424 | 6.460 |
Why?
|
| Medical Errors | 19 | 2024 | 198 | 3.930 |
Why?
|
| Patient Participation | 18 | 2025 | 232 | 3.470 |
Why?
|
| Patient Satisfaction | 16 | 2022 | 439 | 3.360 |
Why?
|
| Decision Making | 20 | 2025 | 416 | 3.290 |
Why?
|
| Physicians | 14 | 2025 | 483 | 3.220 |
Why?
|
| Neoplasms | 17 | 2021 | 1393 | 3.100 |
Why?
|
| Patient-Centered Care | 16 | 2019 | 260 | 3.040 |
Why?
|
| Qualitative Research | 28 | 2025 | 728 | 2.940 |
Why?
|
| Attitude of Health Personnel | 25 | 2025 | 620 | 2.900 |
Why?
|
| Comprehension | 12 | 2023 | 139 | 2.620 |
Why?
|
| Crowdsourcing | 4 | 2024 | 15 | 2.320 |
Why?
|
| Health Knowledge, Attitudes, Practice | 24 | 2024 | 771 | 2.160 |
Why?
|
| Vaccination | 10 | 2025 | 371 | 2.160 |
Why?
|
| Humans | 205 | 2025 | 64283 | 2.090 |
Why?
|
| Quality of Health Care | 15 | 2020 | 526 | 2.030 |
Why?
|
| Truth Disclosure | 10 | 2024 | 58 | 2.020 |
Why?
|
| Primary Health Care | 12 | 2025 | 711 | 2.010 |
Why?
|
| Male | 118 | 2025 | 30322 | 2.010 |
Why?
|
| Anticoagulants | 10 | 2023 | 511 | 2.010 |
Why?
|
| Female | 129 | 2025 | 33382 | 1.970 |
Why?
|
| Adult | 76 | 2025 | 17134 | 1.910 |
Why?
|
| Aged | 83 | 2025 | 14662 | 1.910 |
Why?
|
| Surveys and Questionnaires | 39 | 2024 | 2738 | 1.870 |
Why?
|
| Middle Aged | 78 | 2025 | 17921 | 1.840 |
Why?
|
| Patients | 5 | 2020 | 113 | 1.800 |
Why?
|
| Students, Medical | 16 | 2015 | 269 | 1.710 |
Why?
|
| Health Literacy | 6 | 2023 | 86 | 1.690 |
Why?
|
| Decision Support Techniques | 7 | 2025 | 192 | 1.690 |
Why?
|
| Nursing Homes | 24 | 2023 | 672 | 1.650 |
Why?
|
| Pharmacists | 4 | 2023 | 129 | 1.630 |
Why?
|
| Interviews as Topic | 18 | 2018 | 539 | 1.580 |
Why?
|
| Clinical Competence | 13 | 2024 | 730 | 1.480 |
Why?
|
| Education, Medical, Undergraduate | 10 | 2015 | 161 | 1.440 |
Why?
|
| Educational Measurement | 12 | 2013 | 219 | 1.390 |
Why?
|
| Early Detection of Cancer | 7 | 2025 | 321 | 1.370 |
Why?
|
| Focus Groups | 10 | 2024 | 310 | 1.330 |
Why?
|
| Practice Patterns, Physicians' | 15 | 2021 | 708 | 1.240 |
Why?
|
| Influenza Vaccines | 2 | 2023 | 101 | 1.240 |
Why?
|
| Patient Care | 5 | 2020 | 79 | 1.220 |
Why?
|
| Attitude to Health | 6 | 2020 | 294 | 1.210 |
Why?
|
| Internet | 10 | 2016 | 467 | 1.160 |
Why?
|
| Clinical Trials as Topic | 4 | 2024 | 460 | 1.150 |
Why?
|
| Critical Illness | 4 | 2021 | 327 | 1.130 |
Why?
|
| Text Messaging | 3 | 2025 | 86 | 1.130 |
Why?
|
| United States | 47 | 2024 | 7923 | 1.070 |
Why?
|
| Family | 8 | 2020 | 243 | 1.060 |
Why?
|
| Trust | 4 | 2024 | 79 | 1.010 |
Why?
|
| Internship and Residency | 9 | 2024 | 808 | 1.010 |
Why?
|
| Reading | 4 | 2018 | 93 | 1.000 |
Why?
|
| Reminder Systems | 5 | 2020 | 75 | 0.990 |
Why?
|
| Dementia | 10 | 2024 | 263 | 0.990 |
Why?
|
| Professional-Family Relations | 6 | 2017 | 90 | 0.980 |
Why?
|
| Teaching | 9 | 2007 | 164 | 0.980 |
Why?
|
| Delivery of Health Care | 7 | 2022 | 437 | 0.980 |
Why?
|
| Massachusetts | 21 | 2025 | 2096 | 0.960 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 6 | 2022 | 698 | 0.950 |
Why?
|
| Lung Neoplasms | 4 | 2025 | 696 | 0.940 |
Why?
|
| Randomized Controlled Trials as Topic | 8 | 2024 | 788 | 0.930 |
Why?
|
| Telephone | 4 | 2021 | 122 | 0.860 |
Why?
|
| Patient Safety | 6 | 2018 | 243 | 0.860 |
Why?
|
| Feedback | 5 | 2024 | 93 | 0.850 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2024 | 38 | 0.850 |
Why?
|
| Referral and Consultation | 6 | 2022 | 428 | 0.840 |
Why?
|
| Brain Injuries, Traumatic | 3 | 2021 | 99 | 0.840 |
Why?
|
| Health Maintenance Organizations | 6 | 2012 | 61 | 0.840 |
Why?
|
| Aged, 80 and over | 29 | 2024 | 5528 | 0.830 |
Why?
|
| Pandemics | 4 | 2025 | 676 | 0.820 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2024 | 43 | 0.820 |
Why?
|
| Colorectal Neoplasms | 3 | 2015 | 276 | 0.810 |
Why?
|
| Continuity of Patient Care | 4 | 2017 | 174 | 0.810 |
Why?
|
| Patient Acceptance of Health Care | 5 | 2025 | 489 | 0.790 |
Why?
|
| Physicians, Primary Care | 3 | 2024 | 79 | 0.770 |
Why?
|
| Clinical Decision-Making | 3 | 2020 | 163 | 0.760 |
Why?
|
| Cross-Sectional Studies | 16 | 2024 | 2621 | 0.760 |
Why?
|
| Psychometrics | 6 | 2017 | 385 | 0.740 |
Why?
|
| Young Adult | 20 | 2025 | 4781 | 0.730 |
Why?
|
| Program Evaluation | 7 | 2015 | 490 | 0.710 |
Why?
|
| Pediatrics | 9 | 2019 | 261 | 0.710 |
Why?
|
| Emergency Medicine | 3 | 2019 | 193 | 0.690 |
Why?
|
| Patient Portals | 2 | 2020 | 51 | 0.680 |
Why?
|
| Homes for the Aged | 7 | 2021 | 161 | 0.670 |
Why?
|
| Patient Compliance | 5 | 2012 | 362 | 0.670 |
Why?
|
| House Calls | 1 | 2020 | 23 | 0.660 |
Why?
|
| Reproducibility of Results | 16 | 2020 | 1683 | 0.660 |
Why?
|
| Electronic Health Records | 6 | 2023 | 368 | 0.650 |
Why?
|
| Self-Management | 1 | 2021 | 64 | 0.640 |
Why?
|
| Perception | 4 | 2020 | 178 | 0.640 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 5 | 2024 | 145 | 0.640 |
Why?
|
| Vaccines | 1 | 2021 | 98 | 0.640 |
Why?
|
| Cross Infection | 4 | 2016 | 167 | 0.640 |
Why?
|
| Patient Transfer | 1 | 2020 | 92 | 0.620 |
Why?
|
| Mass Screening | 3 | 2025 | 693 | 0.600 |
Why?
|
| Antipsychotic Agents | 7 | 2024 | 304 | 0.600 |
Why?
|
| Filing | 1 | 2019 | 3 | 0.600 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 147 | 0.590 |
Why?
|
| Electronic Mail | 2 | 2020 | 47 | 0.590 |
Why?
|
| Quality Improvement | 4 | 2019 | 455 | 0.590 |
Why?
|
| Health Care Surveys | 7 | 2019 | 289 | 0.590 |
Why?
|
| Medical Staff, Hospital | 2 | 2018 | 59 | 0.590 |
Why?
|
| Patient Comfort | 1 | 2018 | 2 | 0.580 |
Why?
|
| Professional Competence | 4 | 2008 | 93 | 0.580 |
Why?
|
| Alzheimer Disease | 6 | 2024 | 749 | 0.580 |
Why?
|
| Informed Consent | 4 | 2015 | 141 | 0.580 |
Why?
|
| Medication Errors | 7 | 2023 | 109 | 0.570 |
Why?
|
| Motivation | 2 | 2021 | 289 | 0.570 |
Why?
|
| Checklist | 2 | 2019 | 75 | 0.570 |
Why?
|
| Health Personnel | 5 | 2020 | 389 | 0.560 |
Why?
|
| Preceptorship | 4 | 2005 | 42 | 0.550 |
Why?
|
| Monoclonal Gammopathy of Undetermined Significance | 3 | 2023 | 33 | 0.540 |
Why?
|
| Advance Care Planning | 4 | 2023 | 66 | 0.540 |
Why?
|
| Consumer Health Information | 3 | 2016 | 36 | 0.520 |
Why?
|
| Drug Monitoring | 4 | 2013 | 206 | 0.520 |
Why?
|
| Information Dissemination | 2 | 2017 | 118 | 0.520 |
Why?
|
| Cancer Survivors | 1 | 2018 | 120 | 0.510 |
Why?
|
| Research Personnel | 1 | 2017 | 94 | 0.500 |
Why?
|
| Internal Medicine | 6 | 2024 | 163 | 0.490 |
Why?
|
| Educational Status | 8 | 2013 | 278 | 0.490 |
Why?
|
| Home Nursing | 2 | 2013 | 21 | 0.480 |
Why?
|
| Safety Management | 2 | 2015 | 137 | 0.480 |
Why?
|
| Prescription Drugs | 3 | 2012 | 51 | 0.480 |
Why?
|
| Data Collection | 5 | 2014 | 384 | 0.480 |
Why?
|
| Video Recording | 5 | 2017 | 140 | 0.470 |
Why?
|
| Pilot Projects | 6 | 2025 | 1020 | 0.460 |
Why?
|
| Tamoxifen | 1 | 2015 | 42 | 0.460 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2015 | 36 | 0.460 |
Why?
|
| Program Development | 4 | 2015 | 207 | 0.450 |
Why?
|
| Hospitals | 5 | 2022 | 390 | 0.450 |
Why?
|
| HIV Infections | 3 | 2024 | 976 | 0.450 |
Why?
|
| Risk Assessment | 10 | 2021 | 2048 | 0.450 |
Why?
|
| Prostatic Neoplasms | 2 | 2017 | 421 | 0.450 |
Why?
|
| Adolescent | 17 | 2024 | 6305 | 0.440 |
Why?
|
| Clinical Clerkship | 5 | 2005 | 92 | 0.440 |
Why?
|
| AIDS Vaccines | 1 | 2015 | 72 | 0.440 |
Why?
|
| Colonoscopy | 1 | 2015 | 95 | 0.430 |
Why?
|
| Health Promotion | 2 | 2017 | 505 | 0.420 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2015 | 134 | 0.420 |
Why?
|
| Quality Indicators, Health Care | 3 | 2016 | 335 | 0.420 |
Why?
|
| Faculty, Medical | 6 | 2006 | 200 | 0.420 |
Why?
|
| Managed Care Programs | 3 | 2008 | 89 | 0.420 |
Why?
|
| Home Care Services | 1 | 2014 | 98 | 0.410 |
Why?
|
| Length of Stay | 1 | 2017 | 819 | 0.410 |
Why?
|
| Breast Neoplasms | 4 | 2017 | 1213 | 0.400 |
Why?
|
| Substance Abuse, Intravenous | 2 | 2024 | 80 | 0.400 |
Why?
|
| Community Health Nursing | 1 | 2013 | 10 | 0.400 |
Why?
|
| Quality Assurance, Health Care | 3 | 2019 | 254 | 0.390 |
Why?
|
| Multiple Myeloma | 3 | 2023 | 347 | 0.390 |
Why?
|
| Stroke | 4 | 2020 | 1196 | 0.380 |
Why?
|
| Cluster Analysis | 4 | 2024 | 263 | 0.380 |
Why?
|
| Tobacco Use Disorder | 1 | 2015 | 245 | 0.370 |
Why?
|
| Hepatitis C | 2 | 2024 | 152 | 0.370 |
Why?
|
| Social Support | 1 | 2015 | 376 | 0.370 |
Why?
|
| Healthcare Disparities | 3 | 2024 | 374 | 0.360 |
Why?
|
| Research Design | 5 | 2020 | 583 | 0.360 |
Why?
|
| Videotape Recording | 2 | 2011 | 46 | 0.360 |
Why?
|
| Emergency Service, Hospital | 6 | 2022 | 1118 | 0.360 |
Why?
|
| Patient Preference | 2 | 2018 | 88 | 0.350 |
Why?
|
| Medical Oncology | 1 | 2012 | 68 | 0.350 |
Why?
|
| Patient Education as Topic | 4 | 2024 | 478 | 0.340 |
Why?
|
| Diabetes Complications | 1 | 2011 | 106 | 0.330 |
Why?
|
| Parents | 3 | 2013 | 395 | 0.330 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2010 | 48 | 0.330 |
Why?
|
| Women | 1 | 2010 | 44 | 0.330 |
Why?
|
| Information Seeking Behavior | 3 | 2016 | 38 | 0.330 |
Why?
|
| Medication Systems | 2 | 2021 | 17 | 0.330 |
Why?
|
| Terminal Care | 3 | 2023 | 111 | 0.330 |
Why?
|
| Patient Selection | 4 | 2020 | 487 | 0.320 |
Why?
|
| New England | 5 | 2024 | 269 | 0.320 |
Why?
|
| Computer-Assisted Instruction | 2 | 2007 | 80 | 0.320 |
Why?
|
| Neuroanatomy | 1 | 2009 | 3 | 0.310 |
Why?
|
| Mass Media | 1 | 2010 | 31 | 0.310 |
Why?
|
| Age Factors | 7 | 2016 | 1570 | 0.310 |
Why?
|
| Health Planning Guidelines | 1 | 2009 | 32 | 0.310 |
Why?
|
| Feasibility Studies | 3 | 2020 | 577 | 0.310 |
Why?
|
| Chronic Disease | 4 | 2014 | 756 | 0.310 |
Why?
|
| Hospitalization | 5 | 2023 | 1368 | 0.300 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 457 | 0.300 |
Why?
|
| Mental Recall | 1 | 2009 | 93 | 0.300 |
Why?
|
| Risk Management | 1 | 2009 | 39 | 0.300 |
Why?
|
| Needs Assessment | 4 | 2015 | 203 | 0.300 |
Why?
|
| Consumer Behavior | 1 | 2009 | 38 | 0.300 |
Why?
|
| Education, Medical | 3 | 2007 | 186 | 0.290 |
Why?
|
| Atrial Fibrillation | 4 | 2021 | 854 | 0.290 |
Why?
|
| Inappropriate Prescribing | 3 | 2024 | 68 | 0.280 |
Why?
|
| Attitude to Death | 2 | 2005 | 19 | 0.280 |
Why?
|
| Evidence-Based Medicine | 3 | 2015 | 462 | 0.280 |
Why?
|
| Insurance, Health | 1 | 2009 | 151 | 0.280 |
Why?
|
| Social Behavior | 1 | 2008 | 89 | 0.280 |
Why?
|
| Drug Evaluation | 1 | 2007 | 19 | 0.270 |
Why?
|
| Behavior | 1 | 2007 | 36 | 0.270 |
Why?
|
| Gout | 3 | 2013 | 48 | 0.270 |
Why?
|
| Absenteeism | 1 | 2007 | 39 | 0.270 |
Why?
|
| Retrospective Studies | 7 | 2023 | 6740 | 0.270 |
Why?
|
| Drug Therapy | 1 | 2008 | 56 | 0.270 |
Why?
|
| Child | 10 | 2014 | 4583 | 0.260 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2020 | 161 | 0.260 |
Why?
|
| Drug Labeling | 2 | 2011 | 23 | 0.260 |
Why?
|
| Intensive Care Units | 3 | 2021 | 414 | 0.260 |
Why?
|
| Narration | 1 | 2007 | 51 | 0.260 |
Why?
|
| Influenza, Human | 2 | 2020 | 212 | 0.250 |
Why?
|
| Administrative Personnel | 2 | 2019 | 31 | 0.250 |
Why?
|
| Choice Behavior | 2 | 2017 | 84 | 0.240 |
Why?
|
| Single-Blind Method | 2 | 2024 | 144 | 0.240 |
Why?
|
| Models, Biological | 1 | 2011 | 1187 | 0.240 |
Why?
|
| Correspondence as Topic | 1 | 2005 | 10 | 0.240 |
Why?
|
| Caregivers | 3 | 2024 | 283 | 0.240 |
Why?
|
| Rural Population | 2 | 2024 | 212 | 0.230 |
Why?
|
| Drug Prescriptions | 3 | 2021 | 170 | 0.230 |
Why?
|
| Sex Factors | 6 | 2016 | 980 | 0.230 |
Why?
|
| Warfarin | 3 | 2012 | 122 | 0.230 |
Why?
|
| Cohort Studies | 9 | 2021 | 2605 | 0.230 |
Why?
|
| Liability, Legal | 3 | 2019 | 18 | 0.230 |
Why?
|
| Knowledge | 2 | 2022 | 31 | 0.230 |
Why?
|
| Professional-Patient Relations | 3 | 2015 | 130 | 0.230 |
Why?
|
| Minority Groups | 2 | 2017 | 141 | 0.230 |
Why?
|
| Patient Navigation | 2 | 2016 | 35 | 0.220 |
Why?
|
| Needle Sharing | 1 | 2024 | 15 | 0.220 |
Why?
|
| Health Education | 2 | 2019 | 190 | 0.220 |
Why?
|
| Counseling | 4 | 2022 | 370 | 0.210 |
Why?
|
| Gout Suppressants | 3 | 2013 | 22 | 0.210 |
Why?
|
| Science | 1 | 2004 | 34 | 0.210 |
Why?
|
| Ambulatory Care | 5 | 2023 | 317 | 0.210 |
Why?
|
| Teaching Materials | 1 | 2003 | 12 | 0.210 |
Why?
|
| Hawaii | 2 | 2015 | 22 | 0.210 |
Why?
|
| Drug Users | 1 | 2024 | 27 | 0.210 |
Why?
|
| Georgia | 2 | 2015 | 88 | 0.200 |
Why?
|
| Pregnancy | 5 | 2024 | 2370 | 0.200 |
Why?
|
| Spouse Abuse | 1 | 2003 | 44 | 0.200 |
Why?
|
| Hospice Care | 2 | 2021 | 70 | 0.200 |
Why?
|
| Mobile Applications | 1 | 2024 | 140 | 0.190 |
Why?
|
| Blood Coagulation | 1 | 2022 | 39 | 0.190 |
Why?
|
| Risk Factors | 6 | 2020 | 5341 | 0.190 |
Why?
|
| Precancerous Conditions | 1 | 2023 | 71 | 0.190 |
Why?
|
| Child, Preschool | 6 | 2013 | 2019 | 0.180 |
Why?
|
| Paraproteinemias | 1 | 2022 | 16 | 0.180 |
Why?
|
| Intention | 1 | 2022 | 70 | 0.180 |
Why?
|
| Bias | 1 | 2002 | 114 | 0.180 |
Why?
|
| Accountable Care Organizations | 1 | 2023 | 67 | 0.180 |
Why?
|
| Longitudinal Studies | 2 | 2023 | 1272 | 0.180 |
Why?
|
| Costs and Cost Analysis | 2 | 2023 | 102 | 0.180 |
Why?
|
| Uncertainty | 3 | 2021 | 38 | 0.180 |
Why?
|
| Drug Utilization | 4 | 2020 | 208 | 0.180 |
Why?
|
| Curriculum | 5 | 2013 | 607 | 0.170 |
Why?
|
| Activities of Daily Living | 1 | 2023 | 293 | 0.170 |
Why?
|
| Pharmaceutical Preparations | 2 | 2021 | 123 | 0.170 |
Why?
|
| Antiparkinson Agents | 1 | 2021 | 10 | 0.170 |
Why?
|
| Dopamine Antagonists | 1 | 2021 | 16 | 0.170 |
Why?
|
| Hemorrhage | 1 | 2022 | 275 | 0.170 |
Why?
|
| Job Satisfaction | 2 | 2020 | 141 | 0.170 |
Why?
|
| Patient Simulation | 2 | 2019 | 72 | 0.170 |
Why?
|
| Social Determinants of Health | 1 | 2022 | 141 | 0.160 |
Why?
|
| Bone Density | 2 | 2010 | 137 | 0.160 |
Why?
|
| Ureterolithiasis | 1 | 2020 | 14 | 0.160 |
Why?
|
| Poverty | 3 | 2017 | 299 | 0.160 |
Why?
|
| Prospective Studies | 7 | 2024 | 3318 | 0.160 |
Why?
|
| Metagenomics | 1 | 2019 | 28 | 0.160 |
Why?
|
| Vaccination Coverage | 1 | 2019 | 9 | 0.160 |
Why?
|
| Medical Order Entry Systems | 1 | 2020 | 42 | 0.160 |
Why?
|
| Health Surveys | 2 | 2019 | 314 | 0.150 |
Why?
|
| Medication Adherence | 3 | 2010 | 205 | 0.150 |
Why?
|
| Goals | 1 | 2020 | 92 | 0.150 |
Why?
|
| Cardiologists | 1 | 2019 | 28 | 0.150 |
Why?
|
| Empathy | 2 | 2011 | 68 | 0.150 |
Why?
|
| Pulmonary Artery | 1 | 2020 | 97 | 0.150 |
Why?
|
| Observer Variation | 3 | 2008 | 215 | 0.150 |
Why?
|
| Surgical Procedures, Operative | 1 | 2020 | 142 | 0.150 |
Why?
|
| Documentation | 1 | 2020 | 127 | 0.150 |
Why?
|
| District of Columbia | 1 | 2018 | 9 | 0.150 |
Why?
|
| Connecticut | 6 | 2015 | 87 | 0.150 |
Why?
|
| Maryland | 1 | 2018 | 36 | 0.150 |
Why?
|
| Osteoporosis | 2 | 2010 | 108 | 0.150 |
Why?
|
| Pediatricians | 1 | 2019 | 53 | 0.140 |
Why?
|
| Peripheral Arterial Disease | 2 | 2011 | 160 | 0.140 |
Why?
|
| Frailty | 1 | 2020 | 125 | 0.140 |
Why?
|
| Health Communication | 2 | 2016 | 33 | 0.140 |
Why?
|
| Social Theory | 1 | 2018 | 7 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2020 | 1669 | 0.140 |
Why?
|
| Precision Medicine | 1 | 2019 | 124 | 0.140 |
Why?
|
| Nurses | 1 | 2019 | 109 | 0.140 |
Why?
|
| Cooperative Behavior | 3 | 2019 | 226 | 0.140 |
Why?
|
| Pulmonary Embolism | 1 | 2020 | 175 | 0.140 |
Why?
|
| Peer Group | 2 | 2016 | 104 | 0.140 |
Why?
|
| Diagnostic Errors | 1 | 2019 | 104 | 0.140 |
Why?
|
| Time Factors | 5 | 2021 | 3725 | 0.140 |
Why?
|
| Cholinergic Antagonists | 2 | 2024 | 32 | 0.130 |
Why?
|
| Patient Readmission | 1 | 2021 | 432 | 0.130 |
Why?
|
| Confidence Intervals | 2 | 2013 | 239 | 0.130 |
Why?
|
| Comparative Effectiveness Research | 1 | 2017 | 46 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 3 | 2019 | 726 | 0.130 |
Why?
|
| Causality | 2 | 2010 | 59 | 0.130 |
Why?
|
| Drug Industry | 2 | 2009 | 42 | 0.130 |
Why?
|
| Confidentiality | 1 | 2017 | 57 | 0.130 |
Why?
|
| Multicenter Studies as Topic | 1 | 2017 | 151 | 0.130 |
Why?
|
| Persuasive Communication | 1 | 2017 | 9 | 0.130 |
Why?
|
| Medicare | 4 | 2023 | 611 | 0.130 |
Why?
|
| Peer Review | 1 | 2017 | 26 | 0.130 |
Why?
|
| Psychological Theory | 1 | 2016 | 26 | 0.130 |
Why?
|
| Patient Discharge | 2 | 2017 | 507 | 0.130 |
Why?
|
| Urinary Catheters | 1 | 2016 | 5 | 0.130 |
Why?
|
| Culture | 2 | 2018 | 80 | 0.130 |
Why?
|
| Urethral Obstruction | 1 | 2016 | 6 | 0.130 |
Why?
|
| Harm Reduction | 1 | 2017 | 34 | 0.130 |
Why?
|
| Self Administration | 2 | 2014 | 48 | 0.130 |
Why?
|
| Multilingualism | 1 | 2017 | 23 | 0.130 |
Why?
|
| Noninvasive Ventilation | 1 | 2017 | 69 | 0.130 |
Why?
|
| Urinary Catheterization | 1 | 2016 | 20 | 0.130 |
Why?
|
| Urinary Retention | 1 | 2016 | 29 | 0.120 |
Why?
|
| Friends | 1 | 2016 | 27 | 0.120 |
Why?
|
| Nursing Staff | 2 | 2013 | 40 | 0.120 |
Why?
|
| Regression Analysis | 4 | 2020 | 498 | 0.120 |
Why?
|
| Factor Analysis, Statistical | 3 | 2019 | 99 | 0.120 |
Why?
|
| Organizational Culture | 3 | 2022 | 111 | 0.120 |
Why?
|
| Obesity | 2 | 2023 | 1248 | 0.120 |
Why?
|
| Delayed Diagnosis | 1 | 2015 | 48 | 0.120 |
Why?
|
| Work Schedule Tolerance | 1 | 2015 | 22 | 0.110 |
Why?
|
| Informed Consent By Minors | 1 | 2015 | 4 | 0.110 |
Why?
|
| Health Services Research | 1 | 2016 | 271 | 0.110 |
Why?
|
| Heart Failure | 1 | 2023 | 926 | 0.110 |
Why?
|
| Rationalization | 1 | 2015 | 4 | 0.110 |
Why?
|
| Marketing of Health Services | 1 | 2015 | 22 | 0.110 |
Why?
|
| Infant | 4 | 2016 | 1664 | 0.110 |
Why?
|
| Attitude | 2 | 2008 | 102 | 0.110 |
Why?
|
| Smoking Cessation | 1 | 2020 | 551 | 0.110 |
Why?
|
| Analysis of Variance | 3 | 2007 | 608 | 0.110 |
Why?
|
| Angina, Stable | 1 | 2014 | 11 | 0.110 |
Why?
|
| Evaluation Studies as Topic | 2 | 2005 | 106 | 0.110 |
Why?
|
| Health Behavior | 2 | 2016 | 474 | 0.110 |
Why?
|
| Polypharmacy | 3 | 2024 | 61 | 0.110 |
Why?
|
| Needle-Exchange Programs | 2 | 2024 | 15 | 0.110 |
Why?
|
| Family Health | 1 | 2014 | 69 | 0.110 |
Why?
|
| Data Interpretation, Statistical | 2 | 2007 | 194 | 0.110 |
Why?
|
| Learning | 3 | 2022 | 184 | 0.110 |
Why?
|
| Consultants | 1 | 2014 | 12 | 0.110 |
Why?
|
| Family Nursing | 1 | 2013 | 5 | 0.100 |
Why?
|
| Licensure, Medical | 1 | 2013 | 8 | 0.100 |
Why?
|
| Statistics as Topic | 2 | 2011 | 147 | 0.100 |
Why?
|
| Mothers | 1 | 2017 | 276 | 0.100 |
Why?
|
| Patient Care Team | 2 | 2017 | 340 | 0.100 |
Why?
|
| Critical Care | 1 | 2017 | 402 | 0.100 |
Why?
|
| Independent Living | 1 | 2014 | 52 | 0.100 |
Why?
|
| Medical Staff | 1 | 2013 | 13 | 0.100 |
Why?
|
| Family Practice | 3 | 2005 | 213 | 0.100 |
Why?
|
| Interdisciplinary Studies | 1 | 2013 | 7 | 0.100 |
Why?
|
| Cancer Care Facilities | 1 | 2013 | 18 | 0.100 |
Why?
|
| Aging | 2 | 2022 | 754 | 0.100 |
Why?
|
| Cholesterol, LDL | 2 | 2011 | 104 | 0.100 |
Why?
|
| Ethics, Medical | 2 | 2013 | 40 | 0.100 |
Why?
|
| Geriatric Assessment | 1 | 2014 | 160 | 0.100 |
Why?
|
| Disclosure | 1 | 2013 | 57 | 0.100 |
Why?
|
| Hepacivirus | 2 | 2024 | 140 | 0.100 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 299 | 0.090 |
Why?
|
| Disease Progression | 3 | 2023 | 1176 | 0.090 |
Why?
|
| Databases, Factual | 3 | 2021 | 856 | 0.090 |
Why?
|
| Proxy | 2 | 2023 | 14 | 0.090 |
Why?
|
| Treatment Outcome | 4 | 2020 | 5696 | 0.090 |
Why?
|
| Psychiatry | 1 | 2014 | 127 | 0.090 |
Why?
|
| Organizational Objectives | 1 | 2012 | 58 | 0.090 |
Why?
|
| Bone Density Conservation Agents | 2 | 2010 | 44 | 0.090 |
Why?
|
| Hypercholesterolemia | 1 | 2011 | 70 | 0.090 |
Why?
|
| United Kingdom | 1 | 2011 | 81 | 0.090 |
Why?
|
| Population Surveillance | 1 | 2012 | 209 | 0.090 |
Why?
|
| Online Systems | 1 | 2011 | 20 | 0.090 |
Why?
|
| Health Services Accessibility | 3 | 2017 | 575 | 0.090 |
Why?
|
| Monte Carlo Method | 1 | 2011 | 90 | 0.090 |
Why?
|
| Intermittent Claudication | 1 | 2011 | 52 | 0.090 |
Why?
|
| Disease Notification | 1 | 2011 | 5 | 0.090 |
Why?
|
| Feedback, Psychological | 2 | 2008 | 12 | 0.090 |
Why?
|
| Mandatory Programs | 1 | 2011 | 18 | 0.080 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2014 | 222 | 0.080 |
Why?
|
| Social Identification | 1 | 2010 | 16 | 0.080 |
Why?
|
| Administration, Oral | 2 | 2023 | 374 | 0.080 |
Why?
|
| Self Report | 1 | 2013 | 388 | 0.080 |
Why?
|
| Self Care | 1 | 2012 | 214 | 0.080 |
Why?
|
| Papillomavirus Vaccines | 1 | 2011 | 70 | 0.080 |
Why?
|
| Medicine | 2 | 2011 | 56 | 0.080 |
Why?
|
| Socioeconomic Factors | 2 | 2015 | 788 | 0.080 |
Why?
|
| Moral Obligations | 1 | 2009 | 7 | 0.080 |
Why?
|
| Clinical Protocols | 1 | 2011 | 135 | 0.080 |
Why?
|
| Television | 1 | 2010 | 21 | 0.080 |
Why?
|
| Public Opinion | 1 | 2010 | 25 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 215 | 0.080 |
Why?
|
| Infant, Newborn | 2 | 2013 | 1375 | 0.080 |
Why?
|
| Pamphlets | 2 | 2013 | 17 | 0.080 |
Why?
|
| Interpersonal Relations | 1 | 2010 | 153 | 0.080 |
Why?
|
| Physician-Nurse Relations | 1 | 2009 | 26 | 0.080 |
Why?
|
| Research Subjects | 1 | 2009 | 40 | 0.080 |
Why?
|
| Social Justice | 1 | 2009 | 33 | 0.080 |
Why?
|
| Health Care Sector | 1 | 2009 | 20 | 0.080 |
Why?
|
| Cognitive Dissonance | 1 | 2009 | 5 | 0.080 |
Why?
|
| Physician's Role | 1 | 2010 | 124 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 1105 | 0.080 |
Why?
|
| Guideline Adherence | 1 | 2011 | 306 | 0.080 |
Why?
|
| Marketing | 1 | 2009 | 21 | 0.080 |
Why?
|
| Access to Information | 1 | 2009 | 30 | 0.070 |
Why?
|
| Incidence | 1 | 2013 | 1385 | 0.070 |
Why?
|
| Conflict of Interest | 1 | 2009 | 38 | 0.070 |
Why?
|
| Communication Barriers | 1 | 2009 | 68 | 0.070 |
Why?
|
| Income | 2 | 2022 | 172 | 0.070 |
Why?
|
| Long-Term Care | 2 | 2021 | 177 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 1164 | 0.070 |
Why?
|
| Anecdotes as Topic | 1 | 2007 | 11 | 0.070 |
Why?
|
| Deductibles and Coinsurance | 1 | 2007 | 9 | 0.070 |
Why?
|
| Stress, Psychological | 1 | 2012 | 479 | 0.070 |
Why?
|
| Emotions | 3 | 2006 | 227 | 0.070 |
Why?
|
| Drug Costs | 1 | 2008 | 57 | 0.070 |
Why?
|
| Comorbidity | 3 | 2022 | 1119 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 667 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 709 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2009 | 270 | 0.060 |
Why?
|
| Malpractice | 1 | 2006 | 19 | 0.060 |
Why?
|
| Specialization | 1 | 2006 | 80 | 0.060 |
Why?
|
| Social Networking | 2 | 2016 | 23 | 0.060 |
Why?
|
| Random Allocation | 2 | 2003 | 201 | 0.060 |
Why?
|
| Interprofessional Relations | 3 | 2013 | 137 | 0.060 |
Why?
|
| Health Facility Size | 2 | 2015 | 16 | 0.060 |
Why?
|
| Outpatients | 2 | 2022 | 140 | 0.060 |
Why?
|
| Syringes | 1 | 2024 | 12 | 0.050 |
Why?
|
| Deprescriptions | 1 | 2024 | 28 | 0.050 |
Why?
|
| Faculty | 1 | 2005 | 55 | 0.050 |
Why?
|
| Hypnotics and Sedatives | 1 | 2024 | 65 | 0.050 |
Why?
|
| Logistic Models | 1 | 2008 | 1270 | 0.050 |
Why?
|
| Pragmatic Clinical Trials as Topic | 1 | 2024 | 38 | 0.050 |
Why?
|
| Potentially Inappropriate Medication List | 1 | 2024 | 15 | 0.050 |
Why?
|
| Contusions | 1 | 2003 | 11 | 0.050 |
Why?
|
| Likelihood Functions | 1 | 2003 | 69 | 0.050 |
Why?
|
| Death | 1 | 2003 | 32 | 0.050 |
Why?
|
| Prevalence | 2 | 2019 | 1407 | 0.050 |
Why?
|
| Chi-Square Distribution | 1 | 2003 | 412 | 0.050 |
Why?
|
| Advance Directives | 1 | 2023 | 49 | 0.050 |
Why?
|
| Sampling Studies | 1 | 2002 | 69 | 0.050 |
Why?
|
| Linear Models | 1 | 2003 | 408 | 0.050 |
Why?
|
| Staff Development | 1 | 2003 | 57 | 0.050 |
Why?
|
| International Normalized Ratio | 2 | 2012 | 36 | 0.050 |
Why?
|
| Physicians, Family | 1 | 2002 | 75 | 0.040 |
Why?
|
| Diuretics | 1 | 2021 | 59 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 2021 | 60 | 0.040 |
Why?
|
| Hospitals, Community | 1 | 2021 | 71 | 0.040 |
Why?
|
| Weight Loss | 1 | 2023 | 276 | 0.040 |
Why?
|
| Pharmacy | 1 | 2021 | 19 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2020 | 67 | 0.040 |
Why?
|
| Eligibility Determination | 1 | 2020 | 36 | 0.040 |
Why?
|
| Smoke | 1 | 2020 | 24 | 0.040 |
Why?
|
| Intelligence | 1 | 2020 | 52 | 0.040 |
Why?
|
| Fee-for-Service Plans | 1 | 2020 | 68 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 735 | 0.040 |
Why?
|
| Translations | 1 | 2019 | 6 | 0.040 |
Why?
|
| Medical Overuse | 1 | 2019 | 11 | 0.040 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2020 | 73 | 0.040 |
Why?
|
| Factor Xa Inhibitors | 1 | 2019 | 37 | 0.040 |
Why?
|
| Propensity Score | 1 | 2020 | 167 | 0.040 |
Why?
|
| Preoperative Care | 1 | 2020 | 199 | 0.040 |
Why?
|
| Time-to-Treatment | 1 | 2020 | 115 | 0.040 |
Why?
|
| Self Concept | 1 | 2019 | 113 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2020 | 587 | 0.040 |
Why?
|
| Walking | 1 | 2020 | 240 | 0.040 |
Why?
|
| Validation Studies as Topic | 1 | 2018 | 20 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2015 | 2482 | 0.030 |
Why?
|
| Insurance | 1 | 2017 | 18 | 0.030 |
Why?
|
| Iatrogenic Disease | 1 | 2017 | 59 | 0.030 |
Why?
|
| Third-Party Consent | 1 | 2016 | 9 | 0.030 |
Why?
|
| Behavior Control | 1 | 2016 | 15 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 163 | 0.030 |
Why?
|
| Prognosis | 1 | 2021 | 1769 | 0.030 |
Why?
|
| Biomarkers | 1 | 2022 | 1431 | 0.030 |
Why?
|
| Catheters, Indwelling | 1 | 2016 | 68 | 0.030 |
Why?
|
| Device Removal | 1 | 2016 | 65 | 0.030 |
Why?
|
| Computers | 1 | 2016 | 50 | 0.030 |
Why?
|
| Vulnerable Populations | 1 | 2016 | 89 | 0.030 |
Why?
|
| Registries | 1 | 2019 | 885 | 0.030 |
Why?
|
| Urinary Tract Infections | 1 | 2016 | 93 | 0.030 |
Why?
|
| Off-Label Use | 1 | 2015 | 14 | 0.030 |
Why?
|
| Substance-Related Disorders | 1 | 2002 | 744 | 0.030 |
Why?
|
| Prenatal Care | 1 | 2016 | 174 | 0.030 |
Why?
|
| Fatigue | 1 | 2015 | 114 | 0.030 |
Why?
|
| Boston | 1 | 2015 | 255 | 0.030 |
Why?
|
| Mammography | 1 | 2017 | 290 | 0.030 |
Why?
|
| Machine Learning | 1 | 2016 | 184 | 0.030 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2014 | 167 | 0.030 |
Why?
|
| Child of Impaired Parents | 1 | 2013 | 23 | 0.030 |
Why?
|
| Risk Reduction Behavior | 1 | 2014 | 120 | 0.030 |
Why?
|
| Urban Health Services | 1 | 2013 | 14 | 0.030 |
Why?
|
| Scotland | 1 | 2013 | 9 | 0.030 |
Why?
|
| Models, Educational | 1 | 2013 | 68 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2017 | 870 | 0.020 |
Why?
|
| Uric Acid | 1 | 2013 | 47 | 0.020 |
Why?
|
| Evidence-Based Practice | 1 | 2013 | 84 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2013 | 79 | 0.020 |
Why?
|
| Global Health | 1 | 2014 | 183 | 0.020 |
Why?
|
| Seafood | 1 | 2012 | 14 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2012 | 53 | 0.020 |
Why?
|
| Risk | 1 | 2013 | 379 | 0.020 |
Why?
|
| Exercise | 1 | 2020 | 954 | 0.020 |
Why?
|
| Child Health Services | 1 | 2013 | 64 | 0.020 |
Why?
|
| Meat | 1 | 2012 | 37 | 0.020 |
Why?
|
| Ambulatory Care Facilities | 1 | 2012 | 106 | 0.020 |
Why?
|
| Directive Counseling | 1 | 2011 | 39 | 0.020 |
Why?
|
| Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | 1 | 2011 | 7 | 0.020 |
Why?
|
| Leg | 1 | 2011 | 87 | 0.020 |
Why?
|
| Drug Storage | 1 | 2011 | 22 | 0.020 |
Why?
|
| Health Facilities | 1 | 2011 | 43 | 0.020 |
Why?
|
| Forecasting | 1 | 2011 | 233 | 0.020 |
Why?
|
| Colchicine | 1 | 2010 | 28 | 0.020 |
Why?
|
| Anemia, Sickle Cell | 1 | 2011 | 64 | 0.020 |
Why?
|
| Algorithms | 1 | 2016 | 1029 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2010 | 76 | 0.020 |
Why?
|
| Ankle Brachial Index | 1 | 2010 | 12 | 0.020 |
Why?
|
| Seizures | 1 | 2011 | 143 | 0.020 |
Why?
|
| Bioethical Issues | 1 | 2009 | 7 | 0.020 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2011 | 146 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2012 | 316 | 0.020 |
Why?
|
| Papillomavirus Infections | 1 | 2011 | 132 | 0.020 |
Why?
|
| Quality of Life | 1 | 2016 | 1257 | 0.020 |
Why?
|
| Diet | 1 | 2012 | 533 | 0.020 |
Why?
|
| Health Facility Administrators | 1 | 2008 | 7 | 0.020 |
Why?
|
| Self Efficacy | 1 | 2010 | 203 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2010 | 264 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2010 | 156 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2010 | 930 | 0.020 |
Why?
|
| Treatment Refusal | 1 | 2008 | 56 | 0.020 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2007 | 48 | 0.020 |
Why?
|
| Self Disclosure | 1 | 2006 | 37 | 0.020 |
Why?
|
| Palliative Care | 1 | 2008 | 239 | 0.010 |
Why?
|
| Career Choice | 1 | 2006 | 133 | 0.010 |
Why?
|
| General Surgery | 1 | 2006 | 214 | 0.010 |
Why?
|
| Spirituality | 1 | 2003 | 39 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2005 | 1131 | 0.010 |
Why?
|